A study using these CCA and normal liver organoids found that CCA organoids expressed elevated lysyl-tRNA synthetase (KARS), and treatment of KARS inhibitor cladosporin decreased cell viability of CCA organoid cells, showing potential anti-cancer effects of cladosporin for CCA [58]. The gene discussed is KARS1; the disease is cholangiocarcinoma.